Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited ( (AU:NEU) ) has shared an update.
Neuren Pharmaceuticals Limited has announced a daily buy-back of its ordinary fully paid securities, with a total of 83,848 securities bought back on the previous day. This buy-back initiative is part of the company’s ongoing efforts to manage its capital structure and potentially enhance shareholder value.
More about Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of therapies for neurological disorders. The company is known for its innovative treatments aimed at addressing unmet medical needs in the market.
YTD Price Performance: -11.98%
Average Trading Volume: 852
Technical Sentiment Signal: Buy
Current Market Cap: $904.4M
Find detailed analytics on NEU stock on TipRanks’ Stock Analysis page.